Poster Concept and Topic: “GLP-1 Agonists like Ozempic: A Lifeline for Diabetic and Heart Disease and weight loss.”
Key Points:
Introduction to GLP-1 Agonists:
Explanation of GLP-1 agonists, focusing on Ozempic.
Mechanism of action and how they help manage diabetes.
Benefits for Heart Health:
How GLP-1 agonists reduce the risk of heart attacks and strokes in diabetic patients.
Clinical evidence supporting cardiovascular benefits.
Pharmaceutical Control:
Overview of how pharmaceutical companies control the supply and pricing of GLP-1 agonists.
Impact of pricing on accessibility for patients.
Insurance and Cost Barriers:
Challenges faced by patients in getting insurance coverage for GLP-1 agonists.
Strategies to advocate for better coverage and reduce out-of-pocket costs.
Call to Action:
Encouraging healthcare providers to advocate for their patients.
Empowering patients to understand their rights and options for obtaining necessary medications.
Visual Elements:
Title: Bold and clear, highlighting the importance of GLP-1 agonists.
Infographics: Simple diagrams showing the mechanism of GLP-1 agonists and their benefits for heart health.
Statistics: Data on reduced heart attack and stroke rates with GLP-1 use.
Cost Comparison Chart: Visual representation of the cost barrier created by pharmaceutical companies and insurance coverage.
Patient Testimonials: Short quotes or stories from patients who have benefited from GLP-1 agonists.
Advocacy Section: Steps for patients and providers to take action.
This poster will aim to educate and raise awareness about the critical role of GLP-1 agonists in managing diabetic and heart disease, the barriers to access, and the need for advocacy to improve patient outcomes.
